Acquired by Nordic Capital in December 2021
INOV - Inovalon Holdings, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Bowie,
United States
Type: Equity
INOV price evolution
INOV
| (in millions $) | 30 Sep 2021 | 30 Jun 2021 | 31 Mar 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $108.87 | $117.92 | $128.63 | $123.88 |
| Short term investments | ||||
| Net receivables | $180.58 | $161.24 | $144.76 | $148 |
| Inventory | ||||
| Total current assets | $366.3 | $342.76 | $330.22 | $323.08 |
| Long term investments | ||||
| Property, plant & equipment | $205.11 | $207.98 | $207.56 | $203.47 |
| Goodwill & intangible assets | $1378.82 | $1389.5 | $1396.16 | $1408.44 |
| Total noncurrent assets | $1618.39 | $1632.84 | $1635.78 | $1648.32 |
| Total investments | ||||
| Total assets | $1984.69 | $1975.6 | $1966 | $1971.4 |
| Current liabilities | ||||
| Accounts payable | $44.89 | $47.22 | $47.48 | $53 |
| Deferred revenue | $9.96 | $11.21 | $15.52 | $10.85 |
| Short long term debt | $20.4 | $20.22 | $20.37 | $19.73 |
| Total current liabilities | $152.64 | $153.59 | $152.29 | $164.28 |
| Long term debt | $934.52 | $937.97 | $941.03 | $944.14 |
| Total noncurrent liabilities | $1064.78 | $1076.5 | $1083.98 | $1098.41 |
| Total debt | $954.92 | $958.19 | $961.4 | $963.87 |
| Total liabilities | $1217.41 | $1230.09 | $1236.28 | $1262.68 |
| Shareholders' equity | ||||
| Retained earnings | $331.36 | $319.63 | $310.05 | $300.89 |
| Other shareholder equity | -$34.03 | -$37.03 | -$38.36 | -$47.8 |
| Total shareholder equity | $767.28 | $745.51 | $729.72 | $708.71 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $123.88 | $93.09 | $115.59 | $208.94 |
| Short term investments | $7 | $267.29 | ||
| Net receivables | $148 | $139.51 | $104.41 | $90.05 |
| Inventory | ||||
| Total current assets | $323.08 | $257.24 | $272.13 | $588.71 |
| Long term investments | ||||
| Property, plant & equipment | $203.47 | $192.79 | $141.76 | $125.77 |
| Goodwill & intangible assets | $1408.44 | $1438.92 | $1491.37 | $274.26 |
| Total noncurrent assets | $1648.32 | $1651.4 | $1649.29 | $406.36 |
| Total investments | $7 | $267.29 | ||
| Total assets | $1971.4 | $1908.63 | $1921.41 | $995.08 |
| Current liabilities | ||||
| Accounts payable | $53 | $34.84 | $31.3 | $34.11 |
| Deferred revenue | $10.85 | $13.66 | $23.81 | $6.95 |
| Short long term debt | $19.73 | $20.42 | $12.71 | $45.34 |
| Total current liabilities | $164.28 | $130.36 | $141.31 | $122.09 |
| Long term debt | $944.14 | $945.89 | $953.44 | $203.36 |
| Total noncurrent liabilities | $1098.41 | $1090.12 | $1097.52 | $230.22 |
| Total debt | $963.87 | $966.31 | $966.15 | $248.69 |
| Total liabilities | $1262.68 | $1220.47 | $1238.83 | $352.31 |
| Shareholders' equity | ||||
| Retained earnings | $300.89 | $278.25 | $270.47 | $308.9 |
| Other shareholder equity | -$47.8 | -$26.73 | -$6.74 | -$0.48 |
| Total shareholder equity | $708.71 | $688.16 | $682.59 | $642.77 |
| (in millions $) | 30 Sep 2021 | 30 Jun 2021 | 31 Mar 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $192.23 | $190.44 | $177.18 | $189.75 |
| Cost of revenue | $54.95 | $51.66 | $44.4 | $50.46 |
| Gross Profit | $137.28 | $138.77 | $132.78 | $139.29 |
| Operating activities | ||||
| Research & development | $9.57 | $9.35 | $8.52 | $9.62 |
| Selling, general & administrative | $76.49 | $75.28 | $72.5 | $70.45 |
| Total operating expenses | $118.66 | $114.54 | $109.45 | $108.25 |
| Operating income | $18.62 | $24.24 | $23.33 | $31.03 |
| Income from continuing operations | ||||
| EBIT | $17.64 | $24 | $23.13 | $30.39 |
| Income tax expense | -$6.77 | $1.81 | $1.09 | -$4.1 |
| Interest expense | $13 | $12.86 | $13.13 | $13.71 |
| Net income | ||||
| Net income | $11.41 | $9.33 | $8.91 | $20.78 |
| Income (for common shares) | $11.41 | $9.33 | $8.91 | $20.78 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $667.52 | $642.41 | $527.68 | $449.36 |
| Cost of revenue | $167.82 | $167.81 | $144.83 | $151.05 |
| Gross Profit | $499.7 | $474.6 | $382.85 | $298.31 |
| Operating activities | ||||
| Research & development | $33.5 | $33.69 | $28.64 | $27.38 |
| Selling, general & administrative | $279.56 | $263.17 | $250.57 | $184.05 |
| Total operating expenses | $427.99 | $405.11 | $385.44 | $264.52 |
| Operating income | $71.71 | $69.49 | -$2.58 | $33.79 |
| Income from continuing operations | ||||
| EBIT | $70.97 | $71.47 | -$2.66 | $37.82 |
| Income tax expense | -$7.12 | -$1.9 | -$14.39 | -$2.23 |
| Interest expense | $56.18 | $65.83 | $50.9 | $6.22 |
| Net income | ||||
| Net income | $21.91 | $7.54 | -$39.16 | $33.83 |
| Income (for common shares) | $21.91 | $7.54 | -$39.16 | $33.83 |
| (in millions $) | 30 Sep 2021 | 30 Jun 2021 | 31 Mar 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $11.41 | $9.33 | $8.91 | $20.78 |
| Operating activities | ||||
| Depreciation | $29.65 | $29.91 | $28.43 | $28.18 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $8.42 | $8.28 | $5.66 | $7.4 |
| Total cash flows from operations | $22.14 | $25.09 | $32.44 | $37.25 |
| Investing activities | ||||
| Capital expenditures | -$23.52 | -$22.06 | -$18.44 | -$15.27 |
| Investments | ||||
| Total cash flows from investing | -$26.61 | -$28.76 | -$20.99 | -$24.35 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.11 | |||
| Net borrowings | -$3.21 | -$3.75 | -$3.57 | -$3.56 |
| Total cash flows from financing | -$4.57 | -$7.05 | -$6.69 | -$9.12 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$9.05 | -$10.71 | $4.75 | $3.78 |
| (in millions $) | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 | 31 Dec 2017 |
|---|---|---|---|---|
| Net income | $21.91 | $7.54 | -$39.16 | $33.83 |
| Operating activities | ||||
| Depreciation | $114.92 | $108.25 | $96.72 | $53.09 |
| Business acquisitions & disposals | -$1082.74 | -$3.49 | ||
| Stock-based compensation | $30.53 | $20.23 | $16.16 | $17.32 |
| Total cash flows from operations | $146.36 | $106.48 | $90.4 | $97.71 |
| Investing activities | ||||
| Capital expenditures | -$66.72 | -$58.94 | -$64.97 | -$65.54 |
| Investments | $6.96 | $258.36 | $175.59 | |
| Total cash flows from investing | -$86.61 | -$51.98 | -$889.35 | $106.56 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.2 | $3.67 | $1.83 | -$88.62 |
| Net borrowings | -$14.28 | -$62.19 | $707.13 | -$30.11 |
| Total cash flows from financing | -$28.96 | -$77 | $705.6 | -$123 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $30.79 | -$22.5 | -$93.35 | $81.26 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 155.25M |
| Revenue | $749.59M |
|---|---|
| EBITDA | $211.32M |
| EBIT | $95.16M |
| Net Income | $50.43M |
| Revenue Q/Q | 19.12% |
| Revenue Y/Y | 15.10% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 5.16 |
| Cash/Share | 0.70 |
| EPS | $0.32 |
|---|---|
| ROA | 2.55% |
| ROE | 6.83% |
| Debt/Equity | 1.78 |
|---|---|
| Net debt/EBITDA | 5.25 |
| Current ratio | 2.40 |
| Quick ratio | 2.40 |